{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:29:38Z","timestamp":1786717778838,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Ophthalmol"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/0301-4738.179718","type":"journal-article","created":{"date-parts":[[2016,4,5]],"date-time":"2016-04-05T06:14:11Z","timestamp":1459836851000},"page":"127","source":"Crossref","is-referenced-by-count":8,"title":["Brinzolamide\/timolol versus dorzolamide\/timolol fixed combinations: A hospital-based, prospective, randomized study"],"prefix":"10.4103","volume":"64","author":[{"given":"TamerA","family":"Macky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MaryS","family":"Galose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HebaM","family":"Elsaied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PakinamH","family":"Fouad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0301-4738.179718-1","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The ocular hypertension treatment study: A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma","author":"Kass","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.179718-2","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0161-6420(01)00873-9","article-title":"Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery","author":"Lichter","year":"2001","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.179718-3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/jps.2600630304","article-title":"Drop size and initial dosing frequency problems of topically applied ophthalmic drugs","author":"Chrai","year":"1974","journal-title":"J Pharm Sci"},{"key":"key-10.4103\/0301-4738.179718-4","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/BF02849907","article-title":"Tolerability, quality of life, and persistency of use in patients with glaucoma who are switched to the fixed combination of latanoprost and timolol","author":"Dunker","year":"2007","journal-title":"Adv Ther"},{"key":"key-10.4103\/0301-4738.179718-5","doi-asserted-by":"crossref","unstructured":"Manni G, Denis P, Chew P, Sharpe ED, Orengo-Nania S, Coote MA, et al. The safety and efficacy of brinzolamide 1%\/timolol 0.5% fixed combination versus dorzolamide 2%\/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension. J Glaucoma 2009;18:293-300.","DOI":"10.1097\/IJG.0b013e31818fb434"},{"key":"key-10.4103\/0301-4738.179718-6","doi-asserted-by":"crossref","unstructured":"Sezgin Ak\u00e7ay BI, G\u00fcney E, Bozkurt KT, Unl\u00fc C, Ak\u00e7ali G. The safety and efficacy of brinzolamide 1%\/timolol 0.5% fixed combination versus dorzolamide 2%\/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension. J Ocul Pharmacol Ther 2013;29:882-6.","DOI":"10.1089\/jop.2013.0102"},{"key":"key-10.4103\/0301-4738.179718-7","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression: Results from the early manifest glaucoma trial","author":"Heijl","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.179718-8","first-page":"38","article-title":"Azarga, a new and useful fixed combination in glaucoma treatment","author":"Calugaru","year":"2011","journal-title":"Oftalmologia"},{"key":"key-10.4103\/0301-4738.179718-9","first-page":"714","article-title":"Short-term effect of topical brinzolamide-timolol fixed combination on ocular surface of glaucoma patients","author":"Firat","year":"2012","journal-title":"Int J Ophthalmol"},{"key":"key-10.4103\/0301-4738.179718-10","first-page":"291","article-title":"Efficacy and tolerability of the fixed combination of brinzolamide 1% and timolol 0.5% in daily practice","author":"Lanzl","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"key-10.4103\/0301-4738.179718-11","doi-asserted-by":"crossref","unstructured":"Vold SD, Evans RM, Stewart RH, Walters T, Mallick S. A one-week comfort study of BID-dosed brinzolamide 1%\/timolol 0.5% ophthalmic suspension fixed combination compared to BID-dosed dorzolamide 2%\/timolol 0.5% ophthalmic solution in patients with open-angle glaucoma or ocular hypertension. J Ocul Pharmacol Ther 2008;24:601-5.","DOI":"10.1089\/jop.2008.0030"},{"key":"key-10.4103\/0301-4738.179718-12","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1517\/14656566.2012.705830","article-title":"Fixed topical combinations in glaucomatous patients and ocular discomfort","author":"Nebbioso","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"key-10.4103\/0301-4738.179718-13","first-page":"623","article-title":"A patient preference comparison of Azarga (brinzolamide\/timolol fixed combination) vs Cosopt (dorzolamide\/timolol fixed combination) in patients with open-angle glaucoma or ocular hypertension","author":"Mundorf","year":"2008","journal-title":"Clin Ophthalmol"},{"key":"key-10.4103\/0301-4738.179718-14","doi-asserted-by":"crossref","first-page":"e45079","DOI":"10.1371\/journal.pone.0045079","article-title":"Intraocular pressure-lowering effects of commonly used fixed-combination drugs with timolol: A systematic review and meta-analysis","author":"Cheng","year":"2012","journal-title":"PLoS One"},{"key":"key-10.4103\/0301-4738.179718-15","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2147\/OPTH.S4853","article-title":"Role of fixed-combination brinzolamide 1%\/timolol 0.5% in the treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension","author":"Beckers","year":"2009","journal-title":"Clin Ophthalmol"},{"key":"key-10.4103\/0301-4738.179718-16","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1517\/14656560903124388","article-title":"Brinzolamide\/timolol fixed combination: A new ocular suspension for the treatment of open-angle glaucoma and ocular hypertension","author":"Holl\u00f3","year":"2009","journal-title":"Expert Opin Pharmacother"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:28:09Z","timestamp":1786714089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0301-4738.179718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"alternative-id":["179718"],"URL":"https:\/\/doi.org\/10.4103\/0301-4738.179718","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}